Total Payments
$861.60
2024 Payments
$237.70
Companies
16
Transactions
41
Medicare Patients
3,250
Medicare Billing
$603,677
Payment Breakdown by Category
Food & Beverage$861.60 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $861.60 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $154.44 | 8 | $0 (2024) |
| Averitas Pharma Inc. | $132.29 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $121.91 | 7 | $0 (2018) |
| PFIZER INC. | $109.38 | 4 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $78.65 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $64.14 | 3 | $0 (2019) |
| GRT US Holding, Inc. | $37.48 | 2 | $0 (2022) |
| Egalet US Inc | $30.90 | 2 | $0 (2018) |
| Purdue Pharma L.P. | $22.33 | 1 | $0 (2017) |
| SI-BONE, Inc. | $17.60 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.70 | 8 | ABBVIE INC. ($131.66) |
| 2023 | $49.03 | 2 | Averitas Pharma Inc. ($26.25) |
| 2022 | $51.33 | 3 | GRT US Holding, Inc. ($37.48) |
| 2021 | $82.47 | 5 | Collegium Pharmaceutical, Inc. ($49.76) |
| 2019 | $82.62 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.14) |
| 2018 | $137.42 | 8 | Daiichi Sankyo Inc. ($62.16) |
| 2017 | $221.03 | 11 | PFIZER INC. ($60.49) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/08/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $106.04 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/08/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/27/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Pain Management | ||||||
| 03/02/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Pain Management | ||||||
| 02/01/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Opioid Analgesic | ||||||
| 10/12/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Opioid Analgesic | ||||||
| 07/27/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Opioid Analgesic | ||||||
| 05/25/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Opioid Analgesic | ||||||
| 05/11/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: PENNSAID | ||||||
| 05/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug), RELISTOR | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: PAIN MEDICINE | ||||||
| 05/06/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug), RELISTOR | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: PAIN MEDICINE | ||||||
| 04/08/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/13/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug), RELISTOR | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: PAIN MEDICINE | ||||||
| 11/26/2018 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Addiction Therapy | ||||||
| 11/19/2018 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/10/2018 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 948 | 2,035 | $640,133 | $152,742 |
| 2022 | 19 | 755 | 1,538 | $578,826 | $140,655 |
| 2021 | 18 | 722 | 1,755 | $649,663 | $151,160 |
| 2020 | 18 | 825 | 2,143 | $778,149 | $159,119 |
Total Patients
3,250
Total Services
7,471
Medicare Billing
$603,677
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 385 | $112,201 | $26,437 | 23.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 45 | 130 | $75,400 | $21,074 | 27.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 46 | 66 | $92,400 | $19,889 | 21.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 45 | 76 | $51,224 | $14,077 | 27.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 38 | 63 | $39,375 | $10,113 | 25.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 36 | 56 | $33,880 | $9,928 | 29.3% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 16 | 42 | $12,600 | $7,190 | 57.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 85 | 209 | $41,748 | $6,907 | 16.5% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 16 | 21 | $30,135 | $6,290 | 20.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 39 | 68 | $18,811 | $5,815 | 30.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 38 | 63 | $23,625 | $5,308 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $17,295 | $4,146 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 57 | $11,341 | $2,844 | 25.1% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 11 | 24 | $16,800 | $2,817 | 16.8% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 20 | 31 | $11,005 | $2,053 | 18.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,306 | $1,898 | 26.0% |
| 00104 | Anesthesia for electroshock therapy | Facility | 2023 | 11 | 25 | $13,800 | $1,567 | 11.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 11 | 24 | $8,280 | $1,458 | 17.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 24 | $5,084 | $1,090 | 21.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 64 | 66 | $2,970 | $765.38 | 25.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 18 | $3,582 | $643.00 | 18.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 92 | 536 | $11,271 | $433.65 | 3.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 497 | $144,627 | $34,287 | 23.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 54 | 109 | $73,466 | $21,281 | 29.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 27 | 76 | $44,080 | $12,703 | 28.8% |
About Dr. Angela Lovett, MD
Dr. Angela Lovett, MD is a Anesthesiology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760461297.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Lovett, MD has received a total of $861.60 in payments from pharmaceutical and medical device companies, with $237.70 received in 2024. These payments were reported across 41 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($861.60).
As a Medicare-enrolled provider, Lovett has provided services to 3,250 Medicare beneficiaries, totaling 7,471 services with total Medicare billing of $603,677. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Interventional Pain Medicine
- Location Little Rock, AR
- Active Since 01/12/2006
- Last Updated 08/22/2024
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760461297
Products in Payments
- BOTOX (Biological) $138.09
- QUTENZA (Drug) $132.29
- LYRICA (Drug) $109.38
- Movantik (Drug) $99.55
- LUCEMYRA (Drug) $64.14
- XTAMPZA (Drug) $63.61
- Qutenza (Drug) $37.48
- SPRIX (Drug) $30.90
- Morphabond ER (Drug) $22.36
- HYSINGLA ER (Drug) $22.33
- iFuse Implant (Device) $17.60
- AIMOVIG (Biological) $16.98
- UBRELVY (Drug) $16.35
- Horizant (Drug) $15.92
- VIMOVO (Drug) $15.86
- PENNSAID (Drug) $15.73
- Nucynta (Drug) $15.11
- Xtampza ER (Drug) $15.04
- BUNAVAIL 2.1 mg 30-count box (Drug) $12.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Little Rock
Julio Olaya, M.d, M.D
Anesthesiology — Payments: $22,896
Anesthesiology $22,896
Gregory Smith, M.d, M.D
Anesthesiology — Payments: $15,070
Anesthesiology $15,070
Majid Saleem, Md, MD
Anesthesiology — Payments: $10,579
Anesthesiology $10,579
Dr. Aparna Jindal, Md, MD
Anesthesiology — Payments: $6,860
Anesthesiology $6,860
Ahmed Ghaleb, Md, MD
Anesthesiology — Payments: $6,435
Anesthesiology $6,435
Mr. Mikhail Ivanovsky, Md, MD
Anesthesiology — Payments: $4,564
Anesthesiology $4,564